Meyeon Park

2.1k total citations
40 papers, 754 citations indexed

About

Meyeon Park is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Meyeon Park has authored 40 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Nephrology, 9 papers in Cardiology and Cardiovascular Medicine and 9 papers in Genetics. Recurrent topics in Meyeon Park's work include Chronic Kidney Disease and Diabetes (10 papers), Dialysis and Renal Disease Management (9 papers) and Genetic and Kidney Cyst Diseases (9 papers). Meyeon Park is often cited by papers focused on Chronic Kidney Disease and Diabetes (10 papers), Dialysis and Renal Disease Management (9 papers) and Genetic and Kidney Cyst Diseases (9 papers). Meyeon Park collaborates with scholars based in United States, Canada and Netherlands. Meyeon Park's co-authors include Chi‐yuan Hsu, Michael G. Shlipak, Alan S. Go, Dawei Xie, Rakesh Mishra, Jing Chen, Martin Keane, Daniel L. Dries, Yongmei Li and Amanda Anderson and has published in prestigious journals such as Hepatology, Diabetes Care and Journal of the American Society of Nephrology.

In The Last Decade

Meyeon Park

38 papers receiving 741 citations

Peers

Meyeon Park
Kerry Willis United States
Scott G. Satko United States
Ruth F. Dubin United States
Rajesh Mohandas United States
Eunjeong Kang South Korea
Michael P. Delaney United Kingdom
Udayan Bhatt United States
Sang-Woong Han South Korea
Meyeon Park
Citations per year, relative to Meyeon Park Meyeon Park (= 1×) peers Martin Wagner

Countries citing papers authored by Meyeon Park

Since Specialization
Citations

This map shows the geographic impact of Meyeon Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meyeon Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meyeon Park more than expected).

Fields of papers citing papers by Meyeon Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meyeon Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meyeon Park. The network helps show where Meyeon Park may publish in the future.

Co-authorship network of co-authors of Meyeon Park

This figure shows the co-authorship network connecting the top 25 collaborators of Meyeon Park. A scholar is included among the top collaborators of Meyeon Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meyeon Park. Meyeon Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weber, Ellerie, Lihua Li, Kirsten E. Fleischmann, et al.. (2025). Adherence to GLP ‐1 receptor agonists and SGLT2 inhibitors by out‐of‐pocket spending among Medicare beneficiaries with diabetes. Diabetes Obesity and Metabolism. 27(10). 5683–5693.
2.
Madden, Erin, Michael G. Shlipak, Xiangqin Cui, et al.. (2025). Sodium-Glucose Cotransporter-2 Inhibitor Therapy and Longitudinal Changes in Kidney Function among Veterans with Autosomal Dominant Polycystic Kidney Disease. Clinical Journal of the American Society of Nephrology. 20(7). 940–949. 2 indexed citations
3.
Cui, Di, et al.. (2024). Initial Experience of Metabolic Imaging With Hyperpolarized [1‐13C]pyruvate MRI in Kidney Transplant Patients. Journal of Magnetic Resonance Imaging. 61(4). 1969–1978. 1 indexed citations
4.
Masharani, Umesh, Meyeon Park, M. G. Myriam Hunink, et al.. (2024). Potential Mediators for Treatment Effects of Novel Diabetes Medications on Cardiovascular and Renal Outcomes: A Meta‐Regression Analysis. Journal of the American Heart Association. 13(4). e032463–e032463. 10 indexed citations
5.
Oberdhan, Dorothee, et al.. (2024). Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry. Kidney Medicine. 6(5). 100813–100813. 2 indexed citations
6.
Fleischmann, Kirsten E., Umesh Masharani, Joseph Yeboah, et al.. (2023). Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regression. Diabetes Care. 46(6). 1300–1310. 29 indexed citations
7.
Harris, Orlando, et al.. (2023). Barriers and facilitators to the transplant process among patients living with polycystic kidney disease: a qualitative Approach. BMC Nephrology. 24(1). 119–119. 2 indexed citations
8.
Lassen, Mats Christian Højbjerg, Atif Qasim, Allison B. Webber, et al.. (2021). The effect of kidney transplantation on left ventricular remodeling and global diastolic strain rate in end‐stage renal disease. Echocardiography. 38(11). 1879–1886. 5 indexed citations
9.
Lassen, Mats Christian Højbjerg, Atif Qasim, Tor Biering‐Sørensen, et al.. (2019). Cardiac function assessed by myocardial deformation in adult polycystic kidney disease patients. BMC Nephrology. 20(1). 324–324. 2 indexed citations
10.
Tavakol, Mehdi, Ying Gao, Oana L. Klein, et al.. (2019). The Effect of Enlarged Kidneys on Calculated Body Mass Index Categorization in Transplant Recipients With ADPKD. Kidney International Reports. 4(4). 606–609. 7 indexed citations
11.
Weiner, Daniel E., Meyeon Park, Hocine Tighiouart, et al.. (2018). Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial. American Journal of Kidney Diseases. 73(1). 51–61. 23 indexed citations
13.
Park, Meyeon, Chi‐yuan Hsu, Alan S. Go, et al.. (2017). Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study. Clinical Journal of the American Society of Nephrology. 12(5). 761–771. 53 indexed citations
14.
Huynh, David, et al.. (2017). Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease. BMC Nephrology. 18(1). 214–214. 9 indexed citations
15.
Park, Meyeon, Ameya Kulkarni, Alexis L. Beatty, et al.. (2015). Soluble endothelial cell selective adhesion molecule and cardiovascular outcomes in patients with stable coronary disease: A report from the Heart and Soul Study. Atherosclerosis. 243(2). 546–552. 8 indexed citations
16.
Park, Meyeon, Eric Vittinghoff, Michael G. Shlipak, et al.. (2014). Associations of N-terminal pro–B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study. American Heart Journal. 168(6). 931–939.e2. 15 indexed citations
17.
Chong, Karen, Christopher Owens, Meyeon Park, et al.. (2014). Relationship between kidney disease and endothelial function in peripheral artery disease. Journal of Vascular Surgery. 60(6). 1605–1611. 8 indexed citations
18.
Parikh, Chirag R., Angela J. Yu, Vernon M. Chinchilli, et al.. (2013). Urine Stability Studies for Novel Biomarkers of Acute Kidney Injury. American Journal of Kidney Diseases. 63(4). 567–572. 53 indexed citations
19.
Park, Meyeon, Michael G. Shlipak, Ronit Katz, et al.. (2012). Subclinical Cardiac Abnormalities and Kidney Function Decline. Clinical Journal of the American Society of Nephrology. 7(7). 1137–1144. 26 indexed citations
20.
Park, Meyeon, Steven G. Coca, Sagar U. Nigwekar, et al.. (2010). Prevention and Treatment of Acute Kidney Injury in Patients Undergoing Cardiac Surgery: A Systematic Review. American Journal of Nephrology. 31(5). 408–418. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026